We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
67 hedge funds and large institutions have $136M invested in ADMA Biologics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
433% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 3
386% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 7
137% more call options, than puts
Call options by funds: $303K | Put options by funds: $128K
60% more capital invested
Capital invested by funds: $84.5M → $136M (+$51.1M)
20% more funds holding
Funds holding: 56 → 67 (+11)
10.97% more ownership
Funds ownership: 48.1% → 59.06% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
67
Holders Change
+11
Holders Change %
+19.64%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
34
Reduced
7
Closed
3
Calls
$303K
Puts
$128K
Net Calls
+$175K
Net Calls Change
+$1.69M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$22.1M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$8.57M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$4.93M |
| 4 |
BlackRock
New York
|
+$4.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.47M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$3.23M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$207K |
| 3 |
Barclays
London,
United Kingdom
|
-$167K |
| 4 |
DG
Delek Group
Herzliya,
Israel
|
-$132K |
| 5 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
-$110K |
